John B. Moriarty's Insider Trades & SAST Disclosures

John B. Moriarty's most recent trade in Avidity Biosciences Inc was a trade of 2,374 Common Stock done at an average price of $72.2 . Disclosure was reported to the exchange on Jan. 7, 2026.

Share

Note

This is a custom search result for pattern John B. Moriarty.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Avidity Biosciences Inc	John B. Moriarty	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 72.23 per share.	07 Jan 2026	2,374	74,557	-	72.2	171,474	Common Stock
Avidity Biosciences Inc	John B. Moriarty	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Dec 2025	56,000	103,755	-		0	Common Stock
Avidity Biosciences Inc	John B. Moriarty	Chief Legal Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.87 per share.	17 Dec 2025	26,824	76,931	-	71.9	1,927,841	Common Stock
Avidity Biosciences Inc	John B. Moriarty	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 36.21 per share.	04 Aug 2025	2,245	47,755	-	36.2	81,291	Common Stock
Avidity Biosciences Inc	John Moriarty B.	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jan 2025	50,000	50,000	-		-	Stock Option (Right to Buy)
Avidity Biosciences Inc	Moriarty B. John	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jan 2025	25,000	50,000	-		0	Common Stock
Olema Pharma Inc	John B. Moriarty	EVP, Ch. Legal Officer & Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	150,000	150,000	-		-	Stock Option (Right to Buy)
Olema Pharma Inc	John B. Moriarty	EVP, CH. LEGAL OFFICER & SEC.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2022	166,250	166,250	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades